A recent clinical study published in Issue 18 of Medical Equipment in 2025 provides crucial and specific evidence-based guidance for the early prediction and intervention of neurological complications in patients undergoing cardiac valve replacement surgery under cardiopulmonary bypass. Conducted by a team from Taizhou Hospital in Zhejiang Province, this study analyzed clinical data from 80 patients, not only precisely defining the critical post-operative monitoring window but also establishing the core predictive value and warning thresholds for cerebral oxygen metabolism indicators through quantitative data. Against this backdrop, medical device enterprises represented by Chongqing UTECH Technology Co., Ltd. provide reliable tools through their advanced monitoring systems to translate this data-driven research into clinical practice.

I. Clinical Challenge: The "Silent Killer" Behind Highly Successful Surgeries

Cardiac valve replacement surgery is an effective treatment for valvular heart disease, and the application of cardiopulmonary bypass technology has greatly enhanced procedural safety. However, post-operative neurological complications, such as cognitive dysfunction and delirium, remain severe challenges affecting patients' long-term quality of life, with a non-negligible incidence rate. For a long time, the lack of precise, objective early warning indicators has often led to delayed and passive clinical intervention for such complications.

II. Research Breakthrough: Quantitatively Pinpointing the "First Post-Operative Day" as the Critical Window

This retrospective study from Taizhou Hospital provides clear quantitative evidence. The study divided 80 patients into a non-complication group (63 cases) and a complication group (17 cases), comparing monitoring data at different time points. The most critical finding was on the first post-operative day (T3):

• The mean cerebral tissue oxygen saturation (rScO₂) in the complication group was (63.57 ± 5.38)%, significantly lower than that in the non-complication group (66.69 ± 5.09)% (P=0.030).
• The mean difference between peripheral and cerebral oxygen saturation (da-rScO₂) in the complication group was (33.18 ± 6.41)%, significantly higher than that in the non-complication group (30.37 ± 4.38)% (P=0.038).
• There was no significant difference in peripheral oxygen saturation (SpO₂) between the two groups on post-operative day 1 (P>0.05), highlighting the limitation of relying solely on peripheral SpO₂ monitoring to warn of cerebral risk.

Further statistical analysis strengthens the clinical significance of these findings:

1. Independent Risk Factors: Logistic regression analysis confirmed that rScO₂ and da-rScO₂ are independent influencing factors for neurological complications (OR values 6.895 and 2.750, respectively, P<0.05).
2. Precise Prediction Thresholds: ROC curve analysis showed that rScO₂ has good predictive value for complications (AUC=0.785). The study determined 62.58% as its optimal critical threshold (sensitivity 64.00%, specificity 71.80% at this point). The predictive AUC for da-rScO₂ was 0.590, with a critical threshold of 26.84%.

This data marks a fundamental shift in clinical prevention and control strategy: from "passive response" reliant on symptom appearance to "active early warning and precise intervention" based on objective physiological data (particularly whether rScO₂ falls below 62.58% on post-operative day 1).

III. Solution Implementation: UTECH Technology's Precision Monitoring Equipment

The translation of cutting-edge research into practice relies on reliable tools that can convert data into clinical action. The study clearly requires monitoring to be "continuous" and "precise," and the data confirms that risk differences only become significant on the first post-operative day, necessitating monitoring coverage throughout the entire perioperative period.

The core products of Chongqing UTECH Technology Co., Ltd. provide a complete solution for this need. Its Near-Infrared Cerebral Oxygen Saturation Monitoring System can non-invasively, continuously, and in real-time monitor rScO₂, while simultaneously calculating and displaying the da-rScO₂ value. The system allows for setting warning thresholds. When a patient's post-operative rScO₂ value continuously drops and approaches the 62.58% risk threshold, the device can promptly alarm, prompting immediate intervention by medical staff. This enables interventions such as adjusting ventilator parameters and optimizing hemodynamics to be based on precise data support.

Simultaneously, UTECH Technology's high-precision Pulse Oximeter can integrate with the cerebral oxygen system, providing a comprehensive view of oxygenation status. This perfectly aligns with the research methodology of synchronously monitoring SpO₂ and rScO₂ to calculate the difference (da-rScO₂), directly translating the research findings into a standardized clinical workflow.

IV. Industry Outlook: From Data to Practice, Medical-Engineering Integration

This study, through rigorous data, has charted a clear pathway for preventing and controlling neurological complications after cardiac surgery. UTECH Technology's monitoring technology then becomes the key tool for translating this data map into clinical navigation. In the era of precision medicine, this closed-loop of "clinical problem - research data - device innovation" is the core driving force for improving the prognosis quality of patients undergoing complex surgeries.

Given China's vast population of cardiovascular disease patients, promoting such objective data-based perioperative management protocols is of great significance. In the future, as more clinical evidence accumulates, innovative enterprises represented by UTECH Technology will continue to iterate their technologies, providing more intelligent and integrated monitoring solutions. This will ultimately provide solid technical support for reducing the incidence of neurological complications after cardiac surgery and safeguarding patients' long-term, high-quality lives.